KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas by Heward, JA, Koniali, L, D'Avola, A, Close, K, Yeomans, A, Philpott, M, Dunford, JE, Rahim, T, Al Seraihi, AF, Wang, J, Korfi, K, Araf, S, Iqbal, S, Bewicke-Copley, F, Kumar, E, Barisic, D, Calaminici, M, Clear, AJ, Gribben, JG, Johnson, PWM, Neve, RM, Cutillas, PR, Okosun, J, Oppermann, U, Melnick, A, Packham, G, Fitzgibbon, J